News Details

On March 31, 2026, the National Medical Products Administration (NMPA) of China released a draft announcement for public consultation, proposing updates to the registration and notification requirements for cosmetics. This initiative aims to streamline regulatory procedures further, enhance review efficiency, and support high-quality development of the cosmetics industry. The consultation is open until April 30, 2026. 

Background and Regulatory Context 

The draft was developed to implement the policy outlined in the Opinions on Deepening Cosmetics Regulatory Reform and Promoting High-Quality Industry Development (2025 No. 18), which was issued by the NMPA. 

This reflects the ongoing efforts by Chinese regulators to optimize the regulatory framework for cosmetics and improve the administrative efficiency of product approvals and filings. 
 

Key Highlights of the Draft Proposal 

• Introduces updated requirements for cosmetics registration and notification processes. 

• Aims to simplify administrative procedures and reduce the regulatory burden.  

• Supports innovation and accelerates time-to-market for cosmetic products. 

• Enhances regulatory clarity for both domestic and international companies. 

• Aligns with broader reforms to strengthen post-market supervision. 

Public Consultation Period 

• Consultation start date: March 31, 2026  

• Consultation end date: April 30, 2026  

• Issuing authority: General Office of the National Medical Products Administration (NMPA)  

• Feedback submission: Stakeholders are invited to submit comments via email. 

All feedback should be submitted using the official template provided in the annex and the subject line should indicate that the email contains comments on the cosmetics registration and notification announcement. 

Industry Implications 

If adopted, the proposed reforms are expected to: 

• Improve efficiency in cosmetics product approvals and filings. 

• Provide clearer regulatory pathways for companies entering the Chinese market. 

• Encourage compliance through more transparent and streamlined processes. 

• Strengthen China’s position as a key market for cosmetics innovation. 

Stakeholders, including manufacturers, importers, and regulatory professionals, are encouraged to review the draft carefully and provide feedback during the consultation period.